Zobrazeno 1 - 10
of 460
pro vyhledávání: '"Grootenboer‐Mignot, S."'
Autor:
Dieudonné Y; Department of Clinical Immunology and Internal Medicine, National Reference Centre for Systemic Autoimmune Diseases (CNR RESO), Strasbourg University Hospital, Strasbourg, France.; INSERM UMR-S1109, Université de Strasbourg, Strasbourg, France., Silvestrini MA; U976 HIPI, Hôpital Saint Louis, Université Paris Cité, Paris, France., Dossier A; Department of Internal Medicine, Hôpital Bichat, Université Paris Cité, Paris, France., Meignin V; Department of Pathology, Hôpital Saint Louis, Université Paris Cité, Paris, France., Jouenne F; Laboratoire de Génomique des Tumeurs et Pharmacologie, INSERM UMR-S976, Hôpital Saint Louis, Université Paris Cité, Paris, France., Mahévas T; Department of Dermatology, Hôpital Saint Louis, Université Paris Cité, Paris, France., Bouaziz JD; Department of Dermatology, Hôpital Saint Louis, Université Paris Cité, Paris, France., Jackson MA; U976 HIPI, Hôpital Saint Louis, Université Paris Cité, Paris, France., Mordant P; Department of Thoracic Surgery, Vascular Surgery, and Lung Transplantation, Hôpital Bichat, Université Paris Cité, Paris, France., Poirot J; U976 HIPI, Hôpital Saint Louis, Université Paris Cité, Paris, France., Onodi F; U976 HIPI, Hôpital Saint Louis, Université Paris Cité, Paris, France., Calvani J; Department of Pathology, Hôpital Saint Louis, Université Paris Cité, Paris, France., Hourseau M; Department of Pathology, Hôpital Bichat, Université Paris Cité, Paris, France., Evrard D; Department of Otorhinolaryngology, Hôpital Bichat, Université Paris Cité, Paris, France., Berisha M; National Reference Centre for Castleman Disease, Hôpital Saint Louis, Université Paris Cité, Paris, France., Perrin F; Department of Internal Medicine, Centre Hospitalier de Saint-Nazaire, Saint-Nazaire, France., Danel C; Department of Pathology, Hôpital Bichat, Université Paris Cité, Paris, France., Borie R; Inserm, PHERE, F-75018 Paris, et Hôpital Bichat, APHP, Service de Pneumologie A, FHU APOLLO, Université Paris Cité, Paris, France., Galicier L; National Reference Centre for Castleman Disease, Hôpital Saint Louis, Université Paris Cité, Paris, France.; Clinical Immunology Department, Hôpital Saint Louis, Université Paris Cité, Paris, France., Mourah S; Laboratoire de Génomique des Tumeurs et Pharmacologie, INSERM UMR-S976, Hôpital Saint Louis, Université Paris Cité, Paris, France., Bengoufa D; Immunology laboratory, Hôpital Saint Louis, Université Paris Cité, Paris, France., Oksenhendler E; National Reference Centre for Castleman Disease, Hôpital Saint Louis, Université Paris Cité, Paris, France.; Clinical Immunology Department, Hôpital Saint Louis, Université Paris Cité, Paris, France., Grootenboer-Mignot S; Department of Immunology, Auto-Immunity and Hypersensitivity, Hôpital Bichat, Université Paris Cité, Paris, France., Boutboul D; U976 HIPI, Hôpital Saint Louis, Université Paris Cité, Paris, France.; National Reference Centre for Castleman Disease, Hôpital Saint Louis, Université Paris Cité, Paris, France.; Clinical Immunology Department, Hôpital Saint Louis, Université Paris Cité, Paris, France.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Jul; Vol. 202 (2), pp. 267-278. Date of Electronic Publication: 2023 May 23.
Autor:
Combemale L; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France.; Dermatology Department, Saint Pierre-Brugmann and Queen Fabiola Children's University Hospitals, Université Libre de Bruxelles, Brussels, Belgium., Bohelay G; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Sitbon IY; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Ahouach B; Pathology Department, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Alexandre M; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Martin A; Pathology Department, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Pascal F; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Soued I; Ear, Nose and Throat (ENT) Department, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Doan S; Ophthalmology Department, Assistance Publique des Hôpitaux de Paris (APHP), Bichat Hospital, Paris University, Paris, France., Morin F; Immunology Department, Assistance Publique des Hôpitaux de Paris (APHP), Saint-Louis Hospital, Paris University, Paris, France., Grootenboer-Mignot S; Immunology Department, Assistance Publique des Hôpitaux de Paris (APHP), Bichat Hospital, Paris University, Paris, France., Caux F; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France., Prost-Squarcioni C; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France.; Pathology Department, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France.; Histology Department, Sorbonne Paris Nord University, Bobigny, France., Le Roux-Villet C; Dermatology Department, Referral Center for Autoimmune Blistering Diseases, Assistance Publique des Hôpitaux de Paris (APHP), Avicenne Hospital and Sorbonne Paris Nord University, Bobigny, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Apr 15; Vol. 15, pp. 1243566. Date of Electronic Publication: 2024 Apr 15 (Print Publication: 2024).
Autor:
Weill A; Department of Dermatology, CHU Henri Mondor, AP-HP, Créteil, France.; Referral Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France.; Referral Center for Auto-Immune Bullous Diseases (MALIBUL), AP-HP, Paris, France., Descamps V; Department of Dermatology, CHU Bichat, AP-HP, Paris, France., Chasset F; Faculty of Medicine, Department of Dermatology, CHU Tenon, AP-HP, Sorbonne Université, Paris, France., Mahévas T; Department of Dermatology, CHU Saint-Louis, AP-HP, Paris, France., Bourgault-Villada I; Department of Dermatology, CHU Ambroise Paré, AP-HP, Boulogne Billancourt, France., Wolkenstein P; Department of Dermatology, CHU Henri Mondor, AP-HP, Créteil, France.; Referral Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France.; Referral Center for Auto-Immune Bullous Diseases (MALIBUL), AP-HP, Paris, France.; Univ Paris Est Créteil Epiderm E, Créteil, France., Chollet-Martin S; Department of Immunobiology, CHU Bichat, AP-HP, Paris, France., Ingen-Housz-Oro S; Department of Dermatology, CHU Henri Mondor, AP-HP, Créteil, France.; Referral Center for Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL, Créteil, France.; Referral Center for Auto-Immune Bullous Diseases (MALIBUL), AP-HP, Paris, France.; Univ Paris Est Créteil Epiderm E, Créteil, France., Grootenboer-Mignot S; Referral Center for Auto-Immune Bullous Diseases (MALIBUL), AP-HP, Paris, France.; Department of Immunobiology, CHU Bichat, AP-HP, Paris, France.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Dec; Vol. 36 (12), pp. 2438-2442. Date of Electronic Publication: 2022 Jun 02.
Autor:
Chebani R; Department of Dermatology, Amiens University Hospital, Amiens, France., Lombart F; Department of Dermatology, Amiens University Hospital, Amiens, France., Chaby G; Department of Dermatology, Amiens University Hospital, Amiens, France., Dadban A; Department of Dermatology, Amiens University Hospital, Amiens, France., Debarbieux S, Viguier MA, Ingen-Housz-Oro S, Pham-Ledard A, Bedane CR, Picard-Dahan C, Berthin C, Dereure O, Konstantinou MP, Castel M, Jouen F, Joly P, Seta V, Duvert-Lehembre S, Le Roux C; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Quereux G, Sassolas B, Brenaut E, Sin C, Richard MA, Bérard F, Giusti D, Belmondo T, Gille T, Caux F; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Prost-Squarcioni C; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Grootenboer-Mignot S, Alexandre M; Department of Dermatology and Referral Centre for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2024 Jan 23; Vol. 190 (2), pp. 258-265.
Publikováno v:
In Annales de Dermatologie et de Vénéréologie - FMC April 2022 2(3):223-237
Autor:
Koether K; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Besnard V; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France., Sandig H; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Carruthers A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Miranda E; Imaging and AI, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Grootenboer-Mignot S; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Taillé C; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France., Chevret S; Biostatistics and Clinical Epidemiology team, INSERM UMR 1153, Université de Paris, SBIM- Hôpital Saint Louis, Paris, France., Valeyre D; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Nunes H; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Israel-Biet D; AP-HP, Hôpital Européen Georges Pompidou, Service de Pneumologie, Université de Paris, Paris, France., Lim WK; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Cottin V; Hospices Civils de Lyon, Hôpital Louis Pradel, Université Claude Bernard Lyon 1, Lyon, France., Corkill D; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dobson C; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Groves M; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Ferraro F; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Guenzi E; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Département d'Anatomopathologie, Paris, France., Huang L; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sulikowski M; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mailleux A; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Murray LA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mustelin T; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA., Strickland I; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Sleeman MA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Crestani B; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France bruno.crestani@aphp.fr.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript.
Publikováno v:
The European respiratory journal [Eur Respir J] 2023 May 18; Vol. 61 (5). Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bohelay G; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Inserm UMR 1125 Li2P, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord (USPN), Bobigny, France., Alexandre M; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Le Roux-Villet C; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Sitbon I; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Doan S; Department of Ophthalmology, Bichat University Hospital, AP-HP, Université de Paris, Paris, France., Soued I; Department of ENT and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Bobigny, France., Shourick J; Department of Epidemiology, Clinical Epidemiology and Public Health, UMR 1027 INSERM-University of Toulouse III, Toulouse University Hospital (CHU), Toulouse, France., Rousset L; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Mellottee B; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Heller M; Department of Histology, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord (USPN), Bobigny, France., Lièvre N; Department of Histology, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord (USPN), Bobigny, France., Zumelzu C; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Morin F; Department of Immunology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Saint Louis University Hospital, AP-HP, Université de Paris, Paris, France., Grootenboer-Mignot S; Department of Immunology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Bichat University Hospital, AP-HP, Université de Paris, Paris, France., Gabison E; Department of Ophthalmology, Bichat University Hospital, AP-HP, Université de Paris, Paris, France., Caux F; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Inserm UMR 1125 Li2P, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord (USPN), Bobigny, France., Prost-Squarcioni C; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Department of Histology, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord (USPN), Bobigny, France.; Department of Pathology, Avicenne University Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis (HUPSSD), AP-HP, Université Sorbonne Paris Nord (USPN), Bobigny, France., Musette P; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Inserm UMR 1125 Li2P, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord (USPN), Bobigny, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Jun 30; Vol. 13, pp. 915205. Date of Electronic Publication: 2022 Jun 30 (Print Publication: 2022).
Autor:
Alexandre M; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Bohelay G; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Inserm UMR 1125 Li2P, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord, Bobigny, France., Gille T; Department of Physiology & Functional Explorations, Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Inserm UMR 1272 'Hypoxia & the Lung', UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord, Bobigny, France., Le Roux-Villet C; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Soued I; Department of ENT and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France., Morin F; Department of Immunology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Saint Louis Hospital, AP-HP, Université de Paris, Paris, France., Caux F; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Inserm UMR 1125 Li2P, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord, Bobigny, France., Grootenboer-Mignot S; Department of Immunology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Bichat Hospital, AP-HP, Université de Paris, Paris, France., Prost-Squarcioni C; Department of Dermatology and Referral Center for Autoimmune Bullous Diseases (MALIBUL), Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Department of Pathology, Avicenne Hospital, Hôpitaux Universitaires de Paris Seine-Saint-Denis, AP-HP, Université Sorbonne Paris Nord, Bobigny, France.; Department of Histology, UFR SMBH Léonard de Vinci, Université Sorbonne Paris Nord, Bobigny, France.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Apr 20; Vol. 13, pp. 874108. Date of Electronic Publication: 2022 Apr 20 (Print Publication: 2022).
Autor:
Common M; Dermatology Department, Bichat Claude Bernard University Hospital, Paris, France., El Khalifa J; Dermatology Department, Bichat Claude Bernard University Hospital, Paris, France., Beytout Q; Anatomopathology Department, Bichat Claude Bernard University Hospital, Paris, France., Grootenboer-Mignot S; Immunology Department, Bichat Claude Bernard University Hospital, Paris, France., Deschamps L; Anatomopathology Department, Bichat Claude Bernard University Hospital, Paris, France., Descamps V; Dermatology Department, Bichat Claude Bernard University Hospital, Paris, France.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Feb; Vol. 36 (2), pp. e102-e104. Date of Electronic Publication: 2021 Sep 15.